IR@PKUHSC  > 北京大学第三临床医学院  > 肿瘤放疗科
学科主题临床医学
CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy
Wang, Jun Jie1; Yuan, Hui Shu2; Li, Jin Na1; Jiang, Yu Liang1; Tian, Su Qing1; Yang, Rui Jie1
关键词(125)I seed (103)Pd seed Implantation Brachytherapy Recurrent rectal carcinoma CT-guided
刊名MEDICAL ONCOLOGY
2010-06-01
DOI10.1007/s12032-009-9227-7
27期:2页:421-429
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]COLORECTAL-CANCER ; ABDOMINOSACRAL RESECTION ; RADIATION-THERAPY ; SACRAL RESECTION ; BRACHYTHERAPY ; RADIOTHERAPY ; MANAGEMENT ; PROSTATE ; SURGERY ; DESIGN
英文摘要

The recurrent carcinoma has been difficult to manage after surgery and radiotherapy, extensive resection of locally recurrent rectal cancer is associated with significant morbidity and mortality. Re-irradiation, even in combination with chemotherapy has shown very short survival. We assess the feasibility and efficacy of CT-guided interstitial permanent brachytherapy with (125)I or (103)Pd seeds for recurrent rectal cancer after multiple treatments. Fifteen patients with locally recurrent rectal carcinoma received (125)I or (103)Pd seed implants under CT guidance. The minimal peripheral dose of seed implants was 110-165 Gy (median 150 Gy). Two weeks after seed implantation, a 50 Gy of stereotactic radiotherapy was given to one patient; four patients received 2-4 cycles of chemotherapy. A median follow-up was 8 months (range 4-50 months). The duration of pain-free survival was 0-50 months (median 7 months). Local control was maintained for 3-50 months (median 7 months). The 1- and 2-year local controls were 16.2 and 8.1%, respectively. Eleven patients died: two (18.2%) of local recurrence, seven (63.6%) of local recurrence and metastases, and two (18.2%) of metastases. Four patients (26.7%) survived the median survival was 9 months. The 1- and 2-year actuarial overall survival rates were 42.9% and 10.7%, respectively. One patient (7.6%) experienced a grade 4 toxic event; there was no associated neuropathy. CT-guided radioactive seed implantation is feasible and safe as a salvage or palliative pain relief treatment for patients with recurrent rectal cancers after surgery and radiotherapy.

语种英语
WOS记录号WOS:000277203200039
引用统计
被引频次:19[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67670
专题北京大学第三临床医学院_肿瘤放疗科
作者单位1.Peking Univ, Hosp 3, Ctr Canc, Dept Radiat Oncol, Beijing 100083, Peoples R China
2.Peking Univ, Hosp 3, Dept Radiol, Beijing 100083, Peoples R China
推荐引用方式
GB/T 7714
Wang, Jun Jie,Yuan, Hui Shu,Li, Jin Na,et al. CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy[J]. MEDICAL ONCOLOGY,2010,27(2):421-429.
APA Wang, Jun Jie,Yuan, Hui Shu,Li, Jin Na,Jiang, Yu Liang,Tian, Su Qing,&Yang, Rui Jie.(2010).CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy.MEDICAL ONCOLOGY,27(2),421-429.
MLA Wang, Jun Jie,et al."CT-guided radioactive seed implantation for recurrent rectal carcinoma after multiple therapy".MEDICAL ONCOLOGY 27.2(2010):421-429.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Jun Jie]的文章
[Yuan, Hui Shu]的文章
[Li, Jin Na]的文章
百度学术
百度学术中相似的文章
[Wang, Jun Jie]的文章
[Yuan, Hui Shu]的文章
[Li, Jin Na]的文章
必应学术
必应学术中相似的文章
[Wang, Jun Jie]的文章
[Yuan, Hui Shu]的文章
[Li, Jin Na]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。